Secondary Logo

Journal Logo

Use of Silver-Containing Hydrofiber and Chlorhexidine-Impregnated Tulle Gras Dressings for Second-Degree Burns

Pamuk Cebeci, Sevil PhD; Acaroğlu, Rengin Prof Dr

doi: 10.1097/01.ASW.0000553598.12820.e7
Original Investigation: PDF Only

OBJECTIVE: This study evaluated the use of silver-containing hydrofiber and chlorhexidine-impregnated tulle gras dressings for second-degree burns.

METHODS: This randomized clinical study consisted of 60 patients with second-degree burns. Data were collected using a Patient Identification Form, Wound Assessment Form, and Pain Assessment Scale. Following dressing application, wounds were assessed on days 7, 15, and 22. Study procedures were continued until full epithelialization occurred.

RESULTS: After the seventh day of follow-up, significant improvement was noted in the experimental group in terms of wound exudate, wound debridement, pain intensity, and analgesic agent administration. After the 15th day of follow-up, there was a significant decrease in epithelialization time in the experimental group. Exudate control was better in patients whose burns were treated with silver-containing hydrofiber dressings, and they needed less debridement and fewer analgesics because of infrequent dressing changes. Lower pain scores were reported, the burn area reduced more quickly, and faster epithelialization and wound healing were achieved.

CONCLUSIONS: The authors conclude that silver-containing hydrofiber dressings are an effective wound care material that improve the wound healing process. More studies comparing it and other wound care materials could improve the quality of healthcare for patients with burns.

Sevil Pamuk Cebeci, PhD, is a Physician, Yunus Emre Public Hospital, Eskisehir, Turkey. Rengin Acaroğlu, Prof Dr, is a Professor, Florence Nightingale Nursing Faculty, Istanbul University Health Sciences Institute, Istanbul, Turkey. The authors have disclosed no financial relationships related to this article. Submitted June 12, 2018; accepted in revised form July 23, 2018.

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.